What to expect.
- Calms inflammatory signaling that can interfere with skin repair
- Stimulates collagen and elastin production for firmer skin
- Supports dermal tissue remodeling and wound healing
- Supports deeper tissue repair beneath the surface (BPC-157 / TB-500)
- May reduce the appearance of fine lines and improve skin firmness
- May support hair follicle health alongside skin benefits
- Antimicrobial and antioxidant properties that support overall skin resilience

Dr. Taylor's take
“GHK-Cu has one of the most compelling research profiles of any peptide in the skin category. It works at the level of gene expression and cellular signaling, not as a surface treatment. KPV addresses something different: the inflammatory signaling that can undermine skin repair. With BPC-157 and TB-500 supporting the repair happening beneath the surface, Klow puts all four mechanisms in one physician-supervised protocol.”
Dr. Patrick Taylor, MD · Live Vital physician
About Klow.
Klow is a compounded blend of four peptides: GHK-Cu, KPV, BPC-157, and TB-500, prescribed together to address the structural, inflammatory, and repair sides of skin aging. GHK-Cu is a copper-binding tripeptide found naturally in the body that supports collagen production and tissue remodeling. KPV is a tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH) that calms inflammatory signaling without broadly suppressing the immune system. BPC-157 and TB-500 are repair peptides: BPC-157 supports healing at sites of tissue damage, and TB-500 circulates systemically to support cell migration and tissue remodeling.
The four peptides work on different mechanisms, so combining them is meant to cover ground that no single one would: rebuilding the skin's structural components, supporting repair beneath the surface, and calming the inflammation that can undermine that work. Klow is physician-prescribed after a medical intake with Dr. Taylor, who determines whether the blend fits your skin history and goals.
How it works
KPV inhibits NF-kB activation and reduces production of inflammatory cytokines such as TNF-alpha, IL-6, and IL-1beta, calming the inflammatory signaling that can interfere with tissue repair. GHK-Cu stimulates collagen and glycosaminoglycan synthesis, promotes dermal fibroblast activity, and has been shown to influence genes involved in tissue remodeling and antioxidant response.
BPC-157 and TB-500 add the repair dimension. BPC-157 promotes angiogenesis (new blood vessel formation) and growth factor activity at sites of tissue damage, while TB-500 upregulates actin to support cell migration and remodeling as it circulates. Prescribed together, the four peptides target inflammation, structural rebuilding, and deep tissue repair as separate but connected processes, rather than relying on a single mechanism for overall skin resilience.
Who it may help.
- Individuals with visible signs of skin aging who also deal with chronic skin inflammation
- People who want both collagen support and inflammation control in one protocol
- Those with hair thinning who are also looking for inflammation support
- Individuals seeking a more comprehensive approach to skin resilience than a single-peptide protocol
What to expect, when.
Many patients report early calming of skin inflammation within the first one to two weeks of starting Klow, reflecting KPV's effect on inflammatory signaling. Visible improvements in firmness and fine lines typically follow over the next two to six weeks as GHK-Cu supports collagen and tissue remodeling, with BPC-157 and TB-500 supporting tissue repair beneath the surface over the same period. Any hair-related benefits tend to take longer, often several months, to become noticeable. Outcomes vary by individual, and Dr. Taylor will help set expectations based on your skin history and goals.
Dosing is not one-size-fits-all. Dr. Taylor personalizes your dose and schedule after your medical intake, and adjusts it as your protocol progresses.
Safety information.
Possible side effects
- Mild skin irritation with topical use
- Injection site redness or irritation
- Temporary skin discoloration (rare)
- Mild gastrointestinal discomfort (rare, associated with oral KPV)
- Nausea (rare)
- Headache (infrequent)
- Temporary fatigue
Who should talk to us first
- Active cancer or history of malignancy
- Pregnancy or breastfeeding
- Known copper sensitivity or Wilson disease
- Known hypersensitivity to alpha-MSH-derived peptides
- Active skin infections at the application site
- Active liver or kidney disease
- Concurrent immunosuppressive therapy without medical guidance
- Concurrent use of anticoagulant medications without medical supervision
- Family history of stomach or colon cancer
This information is educational and is not a substitute for medical advice. Every protocol requires a medical intake and physician approval, and outcomes vary by individual.
Standard with every plan.
Doctor-prescribed
Prescribed through Live Vital’s licensed clinical team.
Licensed US pharmacy
Prepared by a licensed US pharmacy and shipped to you.
Unlimited messaging
Reach our care team directly with questions at any time.